ACIU NASDAQ
AC Immune S.A.
1W: +8.3%
1M: -3.9%
3M: +8.8%
YTD: -18.8%
1Y: -10.2%
3Y: -9.0%
5Y: -60.5%
$2.73
-0.09 (-3.02%)
Weekly Expected Move ±7.3%
$2
$3
$3
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$66M
-200.5% ▼
Capital Expenditures
$860K
-49.2% ▼
5Y CAGR: -12.8%
Free Cash Flow
-$67M
-202.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5M
+88.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$73M | -$71M | -$54M | -$51M | -$67M |
| Depreciation & Amort. | $2M | $2M | $2M | $2M | $2M |
| Stock-Based Comp. | $4M | $3M | $4M | $5M | $0 |
| Change in Working Capital | $7M | -$8M | -$15M | $108M | -$6M |
| Other Non-Cash Items | -$6M | -$72K | $2M | $2M | $5M |
| Operating Cash Flow | -$66M | -$74M | -$60M | $66M | -$66M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$1M | -$801K | -$576K | -$860K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $14K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $62M |
| Other Investing | -$51M | $25M | $66M | -$105M | -$162K |
| Investing Cash Flow | -$54M | $24M | $66M | -$105M | $61M |
| — Financing Activities — | |||||
| Net Debt Issuance | $23M | -$569K | -$548K | -$683K | -$1M |
| Stock Repurchased | $0 | -$8K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$6K | -$776K | $0 | -$548K | $46K |
| Financing Cash Flow | $41M | -$1M | $43M | -$1M | -$974K |
| Net Change in Cash | -$79M | -$51M | $47M | -$42M | -$5M |
| Cash End of Period | $82M | $32M | $78M | $36M | $27M |
| Free Cash Flow | -$68M | -$75M | -$61M | $65M | -$67M |